With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: the ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021-2025) >= 10,000 patients followed for >= 5 years (up to 2030) from >= 20 quality-controlled laboratories from >= 10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.

Stress Echo 2030: The Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging / E. Picano, Q. Ciampi, L. Cortigiani, A. Arruda-Olson, C. Borguezan-Daros, E.S.P.J. de Castro, R. Cocchia, E. Bossone, E. Merli, G. Kane, A. Varga, G. Agoston, M. Scali, D. Morrone, I. Simova, M. Samardjieva, A. Boshchenko, T. Ryabova, A. Vrublevsky, A. Palinkas, E. Palinkas, R. Sepp, M. Torres, H. Villarraga, T. Preradović, R. Citro, M. Amor, H. Mosto, M. Salamè, P. Leeson, C. Mangia, N. Gaibazzi, D. Tuttolomondo, C. Prota, J. Peteiro, C. Van De Heyning, A. D'Andrea, F. Rigo, A. Nikolic, M. Ostojic, J. Lowenstein, R. Arbucci, D. Haber, P. Merlo, K. Wierzbowska-Drabik, J. Kasprzak, M. Haberka, A. Camarozano, N. Ratanasit, F. Mori, M. D'Alfonso, L. Tassetti, A. Milazzo, I. Olivotto, A. Marchi, H. Rodriguez-Zanella, A. Zagatina, R. Padang, M. Dekleva, A. Djordievic-Dikic, N. Boskovic, M. Tesic, V. Giga, B. Beleslin, G. Di Salvo, V. Lorenzoni, M. Cameli, G. Mandoli, T. Bombardini, P. Caso, J. Celutkiene, A. Barbieri, G. Benfari, Y. Bartolacelli, A. Malagoli, F. Bursi, F. Mantovani, B. Villari, A. Russo, M. De Nes, C. Carpeggiani, I. Monte, F. Re, C. Cotrim, G. Bilardo, A. Saad, A. Karuzas, D. Matuliauskas, P. Colonna, F. Antonini-Canterin, M. Pepi, P. Pellikka, S. The Stress Echo Study Group Of The Italian Society Of Echocardiography And Cardiovascular Imaging. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 10(2021 Aug 17), pp. 3641.1-3641.35. [10.3390/jcm10163641]

Stress Echo 2030: The Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging

E. Bossone;F. Bursi;G. Bilardo;
2021-08-17

Abstract

With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: the ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021-2025) >= 10,000 patients followed for >= 5 years (up to 2030) from >= 20 quality-controlled laboratories from >= 10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.
effectiveness; registry; stress echocardiography; sustainability;
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
Article (author)
File in questo prodotto:
File Dimensione Formato  
Picano SE2030_JCM2021.pdf

accesso aperto

Descrizione: articolo principale
Tipologia: Publisher's version/PDF
Dimensione 704.7 kB
Formato Adobe PDF
704.7 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/867527
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact